Get startedLog in
    Picture of ALX Oncology Holdings logo

    ALXO — ALX Oncology Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Alx Oncology Announces First Patient Dosed In Aspen-07, A Phase 1 Study Of Evorpacept For The Treatment Of Patients With Urothelial Cancer

    Picture of ALX Oncology Holdings logoALX Oncology Holdings
    16/02/2023 12:40
    Feb 16 (Reuters) - ALX Oncology Holdings Inc  ALXO.O :
    * ALX ONCOLOGY ANNOUNCES FIRST PATIENT DOSED IN ASPEN-07, A
PHASE
1 STUDY OF EVORPACEPT FOR THE TREATMENT OF PATIENTS WITH
UROTHELIAL CANCER

Source text for Eikon:  ID:nGNXfy59W 
Further company coverage:  ALXO.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on ALX Oncology Holdings

    See all news